Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Chief-Executive-Officer"

941 News Found

Plant-based chemistry essential for home and personal care products:  Vishal Sharma, Executive Director & Chief Executive Officer (Chemicals), Godrej Industries
Opinion | July 17, 2025

Plant-based chemistry essential for home and personal care products: Vishal Sharma, Executive Director & Chief Executive Officer (Chemicals), Godrej Industries

Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products


Anurag Yadav is the new Chief Executive Officer of IHH Healthcare India
People | January 17, 2022

Anurag Yadav is the new Chief Executive Officer of IHH Healthcare India

Prior to IHH, Anurag held senior leadership roles in Fortis Healthcare and Manipal Health Enterprises.


Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350
News | June 03, 2026

Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350

DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability


Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision
Biotech | May 26, 2026

Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision

AAV vectors are widely used in gene therapy for their strong therapeutic potential


Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026
R&D | May 25, 2026

Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026

Highlights strong Vibegron results in older men & real-world prostate cancer insights


Apothecon Pharma appoints Shyamakant Giri as Group CEO
People | May 20, 2026

Apothecon Pharma appoints Shyamakant Giri as Group CEO

In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States


IGI’s new drug candidate ISB 2301 to target solid tumors
Biopharma | May 20, 2026

IGI’s new drug candidate ISB 2301 to target solid tumors

The company intends to file an IND submission by the end of this year and begin clinical studies in 2027


ParexelAI launched to accelerate clinical development and improve trial efficiency
Clinical Trials | May 19, 2026

ParexelAI launched to accelerate clinical development and improve trial efficiency

The platform combines internally developed technologies, strategic partnerships, and external AI capabilities


Dr. Reddy’s launches generic semaglutide in Canada
News | May 16, 2026

Dr. Reddy’s launches generic semaglutide in Canada

Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada